NEXENTIS TECHNOLOGIES INC. Increase (Decrease) in Other Operating Liabilities
NEXENTIS TECHNOLOGIES INC. (NXTS) reported Increase (Decrease) in Other Operating Liabilities of $454.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2026-08-13
- NEXENTIS TECHNOLOGIES INC. increase (decrease) in other operating liabilities for the quarter ending 2026-06-30 was $545.00K, a 185.34% increase year-over-year.
- NEXENTIS TECHNOLOGIES INC. increase (decrease) in other operating liabilities for the quarter ending 2026-03-31 was -$91.00K.
- NEXENTIS TECHNOLOGIES INC. increase (decrease) in other operating liabilities for the quarter ending 2025-12-31 was -$455.00K, a 382.61% decline year-over-year.
- NEXENTIS TECHNOLOGIES INC. increase (decrease) in other operating liabilities for the quarter ending 2025-09-30 was $107.00K, a 30.97% decline year-over-year.
- NEXENTIS TECHNOLOGIES INC. increase (decrease) in other operating liabilities for fiscal 2025 was -$164.00K.
- NEXENTIS TECHNOLOGIES INC. increase (decrease) in other operating liabilities for fiscal 2024 was -$169.00K, a 197.69% decline from fiscal 2023.
- NEXENTIS TECHNOLOGIES INC. increase (decrease) in other operating liabilities for fiscal 2023 was $173.00K.
| Period end | Increase (Decrease) in Other Operating Liabilities 3 month | Increase (Decrease) in Other Operating Liabilities 3 month as first filed | Increase (Decrease) in Other Operating Liabilities 6 month | Increase (Decrease) in Other Operating Liabilities 6 month as first filed | Increase (Decrease) in Other Operating Liabilities 9 month | Increase (Decrease) in Other Operating Liabilities 9 month as first filed | Increase (Decrease) in Other Operating Liabilities 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $545.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $454.00K 10-Q · filed 2026-08-13 | -$1.00K derived: sum of 3 quarters · filed 2026-08-13 | $106.00K derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2026-03-31 | -$91.00K 10-Q · filed 2026-05-14 | -$546.00K derived: sum of 2 quarters · filed 2026-05-14 | -$439.00K derived: sum of 3 quarters · filed 2026-05-14 | -$248.00K derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-12-31 | -$455.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$348.00K derived: sum of 2 quarters · filed 2026-03-31 | -$157.00K derived: sum of 3 quarters · filed 2026-08-13 | -$164.00K 10-K · filed 2026-03-31 | |||
| 2025-09-30 | $107.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $298.00K derived: sum of 2 quarters · filed 2026-08-13 | $291.00K 10-Q · filed 2025-11-13 | $452.00K derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-06-30 | $191.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $184.00K 10-Q · filed 2026-08-13 | $345.00K derived: sum of 3 quarters · filed 2026-08-13 | $500.00K derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-03-31 | -$7.00K 10-Q · filed 2026-05-14 | $154.00K derived: sum of 2 quarters · filed 2026-05-14 | $309.00K derived: sum of 3 quarters · filed 2026-05-14 | $148.00K derived: sum of 4 quarters · filed 2026-05-14 | |||
| 2024-12-31 | $161.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $316.00K derived: sum of 2 quarters · filed 2026-03-31 | $155.00K derived: sum of 3 quarters · filed 2026-03-31 | -$169.00K 10-K · filed 2026-03-31 | |||
| 2024-09-30 | $155.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$6.00K derived: sum of 2 quarters · filed 2025-11-13 | -$330.00K 10-Q · filed 2025-11-13 | -$330.48K 10-Q · filed 2024-11-14 | -$91.97K derived: sum of 4 quarters · filed 2025-11-13 | ||
| 2024-06-30 | -$161.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$485.00K 10-Q · filed 2025-08-14 | -$345.57K 10-Q · filed 2024-08-14 | -$246.97K derived: sum of 3 quarters · filed 2025-08-14 | -$217.60K derived: sum of 4 quarters · filed 2025-08-14 | ||
| 2024-03-31 | -$324.00K 10-Q · filed 2025-05-15 | -$323.90K 10-Q · filed 2024-05-15 | -$85.97K derived: sum of 2 quarters · filed 2025-05-15 | -$56.60K derived: sum of 3 quarters · filed 2025-05-15 | -$132.34K derived: sum of 4 quarters · filed 2025-05-15 | ||
| 2023-12-31 | $238.03K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $267.39K derived: sum of 2 quarters · filed 2025-03-31 | $191.66K derived: sum of 3 quarters · filed 2025-03-31 | $173.00K 10-K · filed 2025-03-31 | |||
| 2023-09-30 | $29.37K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$46.36K derived: sum of 2 quarters · filed 2024-11-14 | -$65.03K 10-Q · filed 2024-11-14 | ||||
| 2023-06-30 | -$75.73K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$94.39K 10-Q · filed 2024-08-14 | |||||
| 2023-03-31 | -$18.66K 10-Q · filed 2024-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |